X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Merck Opens Production Facility for Liquid Crystal Window Modules

Yuvraj_pawp by Yuvraj_pawp
30th November 2017
in Facilities & Operation

Merck, a leading science and technology company, today opened a new production facility for liquid crystal window modules in Veldhoven, near Eindhoven, in the Netherlands. The investment of around € 15 million is a further step by Merck to expand its expertise as the market and technology leader in liquid crystals for displays by moving into other applications beyond televisions, laptops, smartphones, and tablet PCs. In 2016, an independent business field was set up for liquid crystal window technology in order to achieve faster market penetration. Merck is the world’s first supplier of this window module technology, which in comparison with previous technologies, offers new application possibilities and regulation within seconds.

Deliveries to start in 2018
“This new facility is a milestone in our strategy to capture new attractive and future-oriented application fields for liquid crystals beyond displays,” emphasized Kai Beckmann, Member of the Executive Board of Merck and CEO Performance Materials, during the inauguration attended by around 100 invited guests from business and politics. “We recently started taking orders from customers for modules that will be ready for delivery as of early 2018. The industry interest in liquid crystal windows we’ve seen so far is very positive.”

Globally, the demand for smart glass is rising. In particular, the construction and automotive industries are looking for long-lived elements that can be integrated both aesthetically and functionally in many shapes and colors. Merck does not see itself as a competitor to glass and window manufacturers, but rather will supply the modules enabling them to make these smart glass elements, windows and façades. In addition, Merck assists architects, designers as well as window and façade makers in an advisory capacity.

For sun protection and privacy applications
In smart glass, liquid crystals regulate light transmission. It serves either as sun or privacy protection. Both variants, which respond within seconds, offer users maximum convenience.

In sun protection applications, exterior blinds and their costly maintenance and repair are unnecessary. The light transmittance of the windows can be lowered down to 5% and set in a continuously variable manner. Energy savings of up to 40% are thus possible with building climate control systems. In both the dark and the bright state, the windows remain transparent and color-neutral and provide an unhindered view outside. Of particular interest to architects is their tremendous flexibility in terms of size and shape as well as the possibilities of their color design with no effect on transparency – a further advantage in addition to switching within seconds – over competing technologies. The privacy variant also switches within seconds from transparent to opaque. It prevents outsiders from being able to look inside conference rooms, restricted production areas or residential buildings.

The liquid crystal materials, which are marketed under the licrivisionTM brand, are also to be used in vehicles in the future. Research is currently underway for further application possibilities, for instance in air and sea travel.

Recognition as an important innovation driver
Long-term tests under real conditions show that innovative liquid crystal windows also live up to their promise in practical applications. Since 2015, the liquid crystal windows in the western façade of Merck’s modular Innovation Center in Darmstadt have been operating perfectly even on hot summer days and icy-cold winter nights. In September 2016, the sun protection and privacy variants were installed in the new OLED production building at the Darmstadt site.

Frost & Sullivan, a global consultancy, has also recognized the potential of the new breakthrough technology. At the end of October, it presented the “Technology Innovation Award” to Merck for its liquid crystal window technology. According to the jury, as a key innovation driver with significant competitive advantage in smart glass, Merck has the opportunity to establish itself as a market leader.

Previous Post

Vaccinex And Catalent Biologics To Collaborate On Antibody-Drug Conjugate Development

Next Post

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

Related Posts

Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Clinical Trials

Oracle Wins the Asia Pacific Biopharma Excellence Awards

21st March 2025
Facilities & Operation

Robust Supply Chains Are Essential For Affordable Drugs

18th May 2024
Essential Elements of Quality Management In Lab Practices
Facilities & Operation

8 Essential Elements of Quality Management In Lab Practices

18th May 2024
Facilities & Operation

FDA Solidifies Its Authority Over Laboratory-Developed Tests

18th May 2024
Facilities & Operation

100% Renewable Electricity Record Hit By Charles River Labs

17th May 2024
Next Post
SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

SQI Diagnostics Completes Sale of Automated Sqidlite Platform to Predictive Cardiac Customer

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In